Methicillin-resistant Staphylococcus aureus — known as MRSA — an antibiotic-resistant germ is increasingly causing skin infections and pneumonia in otherwise healthy children and adults. What’s particularly worrisome is that these infections are being acquired in the community — not the hospital, as has been the usual case until now. Michael Levey’s team at Pharmaceutica in Worcestershire, UK, claims to have discovered a compound that renders the MRSA superbug vulnerable to the antibiotic it normally resists
Share this Story